Malignant Ampulla of Vater Neoplasm — Trials

Malignant Ampulla of Vater Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

51 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 19
Recruiting: 13
Ph III recruiting: 1
Growth YoY: —
Industry share: 5%
Top sponsor: Minia University
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07793253	Phase 2 Study of Daraxonrasib in Recurrent KRAS-Mutant Biliary Tract Cancer	not yet recruiting	Phase 2	55	Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER	1	Aug 28, 2026	clinicaltrials
NCT06062485	Surufatinib Combined With Toripalimab and AG Regiments for First-line Treatment of Unresectable or Relapsing Metastatic Ampullary Carcinoma	not yet recruiting	Phase 2	30	The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER